About: Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1994 (uk) article scientifique publié en 1994 (fr) im Juni 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1994 (ast) scientific article published on 01 June 1994 (en)
publication date	wds:Q72132991-1E91F93C-70ED-410B-B83A-B7B8D8EE3AF5
publication date	1994-06-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q72132991-8009F8FD-CF23-4E7F-8B06-F81C673FC796
exact match	https://scigraph.springernature.com/pub.10.1007/bf00343955
cites work	wds:Q72132991-111D6247-5E69-4B44-9D8B-B911BE4799E6 wds:Q72132991-13760E22-B3F8-4802-B024-7EA27B1D2405 wds:Q72132991-13D69F41-5723-4771-BBCE-10B8524B56E2 wds:Q72132991-14C9B964-E74B-404F-BE43-BEADC8896164 wds:Q72132991-21EF2D2B-F2D4-415A-BA17-7F9C071010F8 wds:Q72132991-289E4D2C-64B2-4E34-88E2-35E0893DC5C2 wds:Q72132991-2B671634-9DFB-4ED3-96EC-BFA4E93E7E2C wds:Q72132991-2C2316B5-A62E-4C71-8340-80C4CA819032 wds:Q72132991-2C50F3E8-641E-47D3-986C-9A3780849EA4 wds:Q72132991-3AF4E5AE-A6A9-458E-9A38-5EAC26EC1336 wds:Q72132991-3E4A8323-06CC-49DA-A0FA-A79FA7B2D0F2 wds:Q72132991-4B50C3B9-C1F9-4D77-8422-1AFFCC42893B wds:Q72132991-4B5CA95E-195F-4E50-99C8-2E565ADF019A wds:Q72132991-55382BF3-D061-4035-A32A-4525350FAD88 wds:Q72132991-5E06DC4E-86A2-4127-B4B1-665A32B1E0D4 wds:Q72132991-5EC18ED2-9C50-4AFA-B975-727D00FAB28B wds:Q72132991-6E089EAA-1A9A-4F63-859B-C6B539A76A12 wds:Q72132991-7C2071A3-7357-4EAB-8352-C78165E4CDEA wds:Q72132991-7C860F04-806F-4632-A56B-9DD2D503BCA7 wds:Q72132991-7DAAE1FA-8FDF-4AEE-A621-E1F6EB7B0DBA wds:Q72132991-8557CD28-FD3A-403D-8F0E-01924D64077F wds:Q72132991-85F1BDD8-E5E9-4B83-A918-6B2E25DCB1E2 wds:Q72132991-8A6305AF-3B2C-4EAB-900F-DE895C0D17C8 wds:Q72132991-9687E55F-F22B-4D21-AE4B-07D50FE46C8C wds:Q72132991-9857E662-41CB-412A-B895-2E633AD79324 wds:Q72132991-A5F6BDFE-207A-49D5-93FF-024E9B3E0AF4 wds:Q72132991-BF906E7F-CACC-4A89-9DD9-9ABAAA674ACE wds:Q72132991-C0D50909-C970-4A03-93EA-4A4461BBCFDB wds:Q72132991-C0E25101-AF72-4313-AF40-426EF4740FA6 wds:Q72132991-C308B429-8966-4B11-A404-BCE51035B25E wds:Q72132991-C53BA8CE-3F74-480C-AF81-8E1C241AAE06 wds:Q72132991-D11DA478-2308-4B67-BAAA-01582B40F7CF wds:Q72132991-D3290B14-3A14-4328-B438-AD06DBDA8817 wds:Q72132991-E13ABF78-2604-4FE5-85EC-F87749580583 wds:Q72132991-E8DE8548-1C4B-447E-BB1B-AA86DBB0C973 wds:Q72132991-EBE9D4C0-CB31-43ED-B9D3-68DD032EA59A wds:Q72132991-F369C122-148D-4848-9730-B3C7D6C5F11E wds:Q72132991-F3990812-D333-41CF-BCE1-A0927447FF96
cites work	Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours Ultrastructural localization of antigenic sites on osmium-fixed tissues applying the protein A-gold technique A glucagonoma syndrome Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing Pancreatic and intestinal processing of proglucagon in man. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man Glucagon-like peptide-1 7-36: a physiological incretin in man. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Mixed endocrine pancreatic tumors producing several peptide hormones Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Glucagon gene sequence. Four of six exons encode separate functional domains of rat pre-proglucagon. Proglucagon processing in a rat islet cell line resembles phenotype of intestine rather than pancreas Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas Effect of glucagon-like peptide-1 on insulin secretion Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects Multipotential phenotypic expression of genes encoding peptide hormones in rat insulinoma cell lines The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500. Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells Glucagon- and glicentin-immunoreactive cells in the human digestive tract Identical mRNA for preproglucagon in pancreas and gut. The role of gut-glucagon-like immunoreactants in the control of gastrointestinal epithelial cell renewal Molecular and cellular analysis of a neoplastic pancreatic A cell tumor Production and characterization of N-terminally and C-terminally directed monoclonal antibodies against pancreatic glucagon Conversion of proglucagon in pancreatic alpha cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences Expression of peptide hormone genes in human islet cell tumors Glucagon 1-21 reduces intestinal epithelial cell proliferation in parenterally fed rats. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas
author name string	wds:Q72132991-2044320F-CA91-4CEC-8927-1B0F893A613A wds:Q72132991-29D0BC63-1DBA-40EC-B4A0-4CD758519A26 wds:Q72132991-2B48715D-77DC-41CF-A3DD-5F43A318BDFB wds:Q72132991-41464B5A-E735-4DE1-B3E9-BCD9BCB1DB62 wds:Q72132991-63FE1E95-C76D-427F-8433-764E968D8F06 wds:Q72132991-7CF11813-4D60-444A-BA99-C1677F2F8590
author name string	B Göke R Arnold R Eissele R Göke H C Fehmann U Weichardt
rdfs:label	Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software